PharmaBoardroom

Interview: Amit Mookim – General Manager, South Asia

Amit Mookim, IQVIA’s general manager for South Asia, discusses the major trends impacting the Indian pharmaceutical market and how Indian companies…

Interview: Stefan Buguslawski – President PEX…

Stefan Buguslawski, president of PEX Pharmasequence, a leading Polish healthcare consultancy and market research company, highlights the current…

Interview: Fernando Silveira F° – Country Manager, ISDIN,…

Fernando Silveira F°, country manager in Brazil of ISDIN, documents the successful market entry and rapid development of this dermatology focused…

Interview: Sylvain Chrétien – CEO, Pediapharm, Canada

Sylvain Chrétien, CEO of Pediapharm, introduces the pediatrics-focused company he founded in 2008, having identified a number of unmet needs in the…

Interview: Leonas Kalėtinas – Executive Director,…

Leonas Kalėtinas, executive director at the Lithuanian Innovative Pharmaceutical Industry Association (IFPA), explains the main dynamics impacting…

Interview: Laurent-Dominique Piveteau – CEO, Debiotech,…

Laurent-Dominique Piveteau, CEO of Swiss medtech innovator Debiotech, discusses digital disruption, Swiss innovation, and future growth drivers. As…

Interview: Predrag Lukic – General Manager Serbia, Regional…

Predrag Lukic, general manager of Amicus, a new and exciting bridging service for MNCs looking to expand into Serbia and the Balkans, reveals the keys…

UK Life Sciences Firms Struggle in Post-Brexit War for EU Talent

UK pharmaceutical and biotech companies are already finding it increasingly difficult to attract talent from overseas. Additionally, UK firms are…

Interview: Luis Fernando Lenski – Head of South Cone and…

Luis Fernando Lenski, head of South Cone and general manager of Galderma Brazil, provides insights into the affiliate’s heightened and tireless…

Interview: Piotr Ponikowski – President, Polish Cardiac…

Piotr Ponikowski, president of the Polish Cardiac Society, discusses the positive steps Poland is taking to construct an effective program against…

Interview: Alessandro di Napoli – CEO, TRB Chemedica,…

Alessandro di Napoli, CEO of Swiss family-owned pharmaceutical group, TRB Chemedica, discusses the company’s focus on the rheumatology,…

Interview: Šarūnas Narbutas – President, Lithuanian…

Šarūnas Narbutas, president at the Lithuanian Cancer Patients’ Coalition (POLA), explains the role of patients in shaping the Lithuanian…

Tagged with